Cargando…
Current and experimental therapeutics for Fabry disease
Fabry (or Anderson‐Fabry) is a rare pan‐ethnic disease affecting males and females. Fabry is an X‐linked lysosomal storage disease, affecting glycosphingolipid metabolism, that is caused by mutations of the GLA gene that codes for α‐galactosidase A. Fabry disease (FD) can be classified into a severe...
Autores principales: | Castelli, Vanessa, Stamerra, Cosimo Andrea, d'Angelo, Michele, Cimini, Annamaria, Ferri, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453747/ https://www.ncbi.nlm.nih.gov/pubmed/33997974 http://dx.doi.org/10.1111/cge.13999 |
Ejemplares similares
-
Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
por: d’Angelo, Michele, et al.
Publicado: (2020) -
Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021) -
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
por: D’Egidio, Francesco, et al.
Publicado: (2023) -
The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?
por: Castelli, Vanessa, et al.
Publicado: (2020) -
Looking for In Vitro Models for Retinal Diseases
por: Alfonsetti, Margherita, et al.
Publicado: (2021)